BACKGROUND: In our previous studies, chronic treatment of rats with a new b b 3 -adrenoceptor agonist, CL 316,243, retarded diet-induced obesity and promoted thermogenesis in young animals and reversed established diet-induced obesity in older animals that continued to eat a high fat diet. Reversal of obesity was associated with shrinking of enlarged white adipocytes but the number of mature white adipocytes, which had not been increased by the diet, was not reduced. Drug-treatment induced appearance of abundant brown adipocytes in white adipose tissue (WAT) depots as well as hypertrophy of brown adipose tissue (BAT) in both lean and diet-induced obese rats. OBJECTIVES: To ®nd out whether the known hyperplasia of white adipocytes in the obese fa/fa rat could be reversed by CL 316,243-treatment and whether the grossly enlarged WAT depots of the obese fa/fa rat contain precursors to brown adipocytes. RESULTS: CL 316,243 infusion (1 mg/kg/d) reduced abdominal fat. The loss of fat was due to a decrease in white adipocyte size, with no loss of the markedly elevated number of adipocytes in the fa/fa rats. Resting metabolic rate increased by 40% in lean rats, by 70% in fa/fa rats. Food intake decreased in the hyperphagic fa/fa rats but did not change in lean rats. In both lean and fa/fa rats, a marked increase in protein content of retroperitoneal WAT was associated with appearance of abundant densely-stained brown adipocytes expressing uncoupling protein (UCP) but total number of cells (from DNA content) actually decreased. Hyperinsulinemia and hyperglycemia of fa/fa rats were reduced by treatment, indicating improved sensitivity to insulin. CONCLUSIONS: Abundant precursors to brown adipocytes are present in WAT depots of fa/fa rats and much of the exaggerated increase in resting metabolic rate induced by CL 316,243 occurs in these cells. This b b 3 -adrenoceptor agonist is an effective anti-obesity and anti-diabetic agent in fa/fa rats. It does not bring about disappearance of mature white adipocytes but does bring about a remodelling of WAT, with a marked change in cell composition.
1±3 b 3 -Adrenoceptors in white and brown adipose tissues (WAT and BAT) can serve as a target for the treatment of obesity. 4, 5 Stimulation of these adrenoceptors increases lipid mobilization in WAT and accelerates fat oxidation in BAT, reducing lipid stores in both tissues. In a previous study we demonstrated that chronic treatment of young growing rats with CL 316,243 (CL) for two weeks retarded the development of obesity induced by a high-fat diet. 6 In a second study we demonstrated that treatment with CL could reverse already established diet-induced obesity in older rats that continued to eat a high-fat diet. 7 In this second study, multilocular cells that appeared in WAT of the CL-treated rats were identi®ed as brown adipocytes, based on their expression of uncoupling protein (UCP). 8 These brown adipocytes in WAT, together with the brown adipocytes already present in BAT, themselves also hypertrophied by the treatment, were suggested to be the site of the large increase in resting metabolic rate that was seen. The increased energy expenditure, together with unchanged food intake in the presence of the drug, led to negative energy balance and rapid loss of fat. The loss of adipose mass was due to shrinking of the enlarged white adipocytes with no change in their number. However, the diet-induced obesity had not induced any increase in white adipocyte number; it was a hypertrophic obesity. One objective of the present study was to ®nd out whether mature white adipocytes could be made to disappear by the drug-treatment in a model of obesity in which their number would already be much elevated. The old fa/fa rat was chosen for study because it is well-known to have hyperplastic obesity. 9 A second objective was to ®nd out whether precursors to brown adipocytes are present in the much enlarged WAT depots of the fa/fa rat. In addition, possible amelioration of the diabetic state of the fa/fa rat was assessed by measuring blood glucose and insulin levels.
Methods

Animals
Twenty-four lean and 24 genetically obese fa/fa rats were purchased from Charles River, Canada at 11±12 weeks of age. They were housed at 24 C in plastic cages with wood chip bedding and with free access to chow (Agway R-M-H 4020 chow, 14.5% energy from fat) and water until they reached 30 weeks of age. At this time, one group of eight of each genotype was killed (week 0). Two groups of eight from each genotype group were then implanted with osmotic minipumps (Alzet 2002, Alza, Palo Alto CA) under halothane anesthesia and received 0.49 ml per hour containing either saline or CL 316,243 (daily dose was 1 mg kg
71
) for the next 2±3 weeks. Pumps were replaced after two weeks. Body weights and food intakes were measured weekly. Resting metabolic rates were measured during the second or third week of treatment with saline or CL by placing the rat in a water-jacketed chamber at 28 C, volume 1 l, through which air, also at 28 C, was drawn at a rate of 1 l per minute (regulated with a mass¯owmeter, Brooks Instrument Division, Emerson Electric, Co. Hat®eld, PA). Oxygen concentration in the air entering and leaving the chamber was measured with an oxygen analyzer (Beckman Industrial Oxygen Analyzer Model 755) and computerized data acquisition and handling to obtain oxygen uptake by the rat as described before. 6 Some CL-treated fa/fa rats died by the end of the second week. The remainder of this group plus the saline-treated fa/fa rats were therefore studied immediately. The CL-treated and saline-treated lean rats were studied as soon as possible thereafter. Rats were killed by decapitation. Interscapular and perirenal BAT depots were removed and placed in isolation medium on ice. 6, 10 They were then dissected free of adhering muscle, vasculature and white adipose tissue, weighed and frozen. Retroperitoneal WAT (RWAT) and epididymal WAT depots were removed and weighed. Weighed portions were used for osmium ®xation for counting and sizing of mature adipocytes.
11 Some samples were taken for histology (see below). The remainder was weighed and frozen. The remaining carcass had tail and paws removed and was frozen for later carcass analysis. For carcass analysis, carcasses were autoclaved, then homogenized in water (Waring Blendor, commercial heavy duty). Duplicate samples of homogenate were placed in extraction thimbles, allowed to drain and dry, then the fat extracted (Soxhlet extraction) and weighed.
Assays
Frozen tissue samples were homogenized in isolation medium. Protein was measured by a modi®ed Lowry method and UCP was measured by solid-phase radioimmunoassay in homogenates of BAT as before. 10 DNA was measured in delipidated WAT and BAT homogenates with a dye binding (Hoechst 33258) uorometric method and UCP in WAT was assessed by gel electrophoresis followed by Western blotting, both as described previously. 10 
Histology
Some samples of WAT were ®xed in 10% buffered formalin solution and then embedded in paraf®n. Thick (7±10 mm) sections were either stained with hematoxylin and eosin or were subjected to immunohistochemistry for UCP. For immunohistochemistry, sections were incubated with a primary antibody to UCP diluted 1:100 with Tris buffer-carageenan (0.6%)-Triton X-100 (0.3%) (TCT) overnight at 4 C. The antiserum for hamster UCP had been raised in rabbits and stored in glycerol 1:1 at 720 C. The next day they were washed in Tris-buffered saline (TBS) (0.1 M Tris and 0.14 M sodium chloride) and incubated with a secondary antibody (donkey anti-rabbit Ig, biotinylated whole antibody) diluted 1:50 in TCT buffer. After further washing in TBS and neutralization with 3% hydrogen peroxide sections were washed again in TBS and incubated with streptavidin-horseradish peroxidase conjugate diluted with TCT at room temperature. They were further washed in TBS, then incubated with diaminobenzidene (200 mg/100 ml TBS plus 700 ml nickel chloride plus 10 ml hydrogen peroxide) in the dark. Sections were then dehydrated in alcohol, cleared in xylol and mounted in Permount. 12 Some 10 mm sections were stained with propidium iodide and viewed by¯uorescence microscopy to observe the nuclei. Some samples of WAT were ®xed in buffered glutaraldehyde solution and embedded in Epon. Semi-thin sections (0.5 mm) were cut and stained with methylene blue and azur II. 6 
Statistical analysis
Results are presented as means AE s.e.m. Statistical analysis used Instat software to do ANOVA followed by Student-Newman-Keuls post hoc test. Signi®cant differences are based on P`0.05.
Results
The fa/fa rats weighed more than the lean rats but their weights were highly variable; because of this variation mean weight was not signi®cantly altered by the CL-treatment (Table 1) . However, the fa/fa rats which survived lost an average 56 AE 16.9 g in two weeks and the fa/fa rats which did not survive for two weeks had lost an average of 35.5 AE 3.8 g in the ®rst week of treatment. Abdominal fat content, ®ve-fold higher in the fa/fa rats, was reduced by the CLtreatment ( Figure 1A ). Further accretion of fat in other locations ceased but no reduction occurred ( Figure 1B ). The fa/fa rats were hyperphagic and their food intake was reduced by the CL-treatment ( Figure 2A ). Food intake of lean rats was not altered by the CL-treatment ( Figure 2A ). Resting metabolic rate was slightly higher in the fa/fa rats compared with the lean rats ( Figure 2B ). CL-treatment increased resting metabolic rate by 70% in the fa/fa rats and by 40% in the lean rats ( Figure 2B) ; the absolute increase, in ml oxygen per minute per rat, was threefold greater in the fa/fa rats. Rectal temperatures were not altered by the CL-treatment (legend to Figure 2 ).
Both retroperitoneal and epididymal WAT depots were studied. Data are presented only for RWAT; changes in epididymal WAT were similar but usually of lesser magnitude. In fa/fa rats, wet weight of RWAT was almost 10 times that in lean rats and was reduced by 35% by the CL-treatment ( Table 1) . Weight of RWAT was also reduced by the CL-treatment in the lean rats ( Table 1 ). The average size of white adipocytes was normal in the fa/fa rats and was reduced by the CL-treatment in both fa/fa and lean rats ( Figure 3A ). The number of mature white adipocytes was about seven times greater in the fa/fa rats than in the lean rats ( Figure 3B ). It was not reduced by CL-treatment although further accretion of cells with age appeared to cease ( Figure 3B ). In epididymal WAT of fa/fa rats, there was only a moderate increase in number of white adipocytes of 26% but the adipocytes were larger (0.95 AE 0.047 vs 0.69 AE 0.025 mg of lipid). The size was reduced by CL-treatment but the number was not altered (data not shown). Protein content of RWAT was substantially increased by the CL-treatment in both lean and fa/fa rats ( Figure 4B ).
DNA content of RWAT was ten-fold higher in fa/fa rats than in lean rats and was reduced by CL-treatment in both fa/fa and lean rats ( Figure 4A ). Calculation of the contribution of the number of mature white adipocytes (as assessed by counting of osmium ®xed cells) to total cell number (as expressed by DNA content) suggested a much lower proportion than has frequently been assumed, about 0.5±0.7% (Table 1) .
Interpretation of the CL-induced changes in weight of RWAT, in size of mature white adipocytes and in DNA content (all decreased), in the number of mature white adipocytes (unchanged) and in protein content (increased) in the obese rats suggested a marked remodelling of the tissue that needed further histological characterization. Routine histology of RWAT of saline-treated lean and fa/fa rats showed the typical appearance of numerous unilocular white adipocytes, apparently the predominant cell type in the tissue ( Figure 5 ). In fa/fa rats there was a large range of sizes whereas size was more uniform in the lean rats ( Figure 5 ). Histology of RWAT of CL-treated lean and fa/fa rats revealed unilocular white adipocytes that were smaller than those in saline-treated rats and, in addition, abundant more densely stained and much smaller cells, many with a multilocular appearance ( Figure 5 ). Immunohistochemistry showed that these multilocular cells contained UCP, not visible at all in RWAT of the saline-treated rats ( Figure 6 ). Higher power light microscopy of semi-thin sections showed the multilocular cells to have densely-stained cytoplasm, numerous very small lipid droplets and large pale nuclei with a prominent nucleolus, all characteristic of brown adipocytes ( Figure 7 ). They were associated with numerous capillaries. In RWAT of Treatment of obese fa/fa rats with CL 316,243 M Ghorbani and J Himms-Hagen CL-treated fa/fa rats the multilocular cells frequently clustered around mature white adipocytes ( Figure 7) . Western blotting showed the presence of a 32 kDa protein in CL-treated rats, identi®ed as UCP (not shown).
The calculated low contribution of mature white adipocytes, as assessed by osmium ®xation, to total cells, as assessed by DNA content (Table 1) , was not obvious from examination of routine histology of RWAT of saline-treated rats ( Figure 5 ) but was suggested by the appearance of RWAT in the CLtreated animals ( Figure 5 ). To visualize this low contribution, 10 mm sections were stained with propidium iodide and viewed by¯uorescence microscopy to see all the nuclei present in the section. Since mature white adipocytes have average diameters of 80±120 mm, relatively few adipocyte nuclei can be expected to be present in 10 mm sections. The appearance of these sections suggests the presence of abundant non-adipocyte nuclei in RWAT even in salinetreated rats (Figure 8 ). These non-adipocyte nuclei are more apparent in RWAT of the CL-treated rats because the size of the adipocytes has decreased markedly so that the same volume of section contains far more of the non-adipocyte nuclei.
Both interscapular and perirenal BAT depots were studied. Data are presented only for interscapular BAT (IBAT); changes in perirenal BAT were similar. Protein content and UCP content were increased Figure 1 Body fat in lean and fa/fa rats. Panel A shows fat content of two major abdominal depots (epididymal and retroperitoneal). CL-treated rats indicated by sold circles; all other groups indicated by solid squares. S is saline. Dotted lines link values for fa/fa rats; solid lines link values for lean rats. All rats ate chow. CL-fa/fa vs S-fa/fa at 2 weeks, P`0.05, and vs fa/fa at 0 weeks, P`0.01. S-fa/fa at 4 weeks vs fa/fa at 0 weeks, N.S. CL-lean vs S-lean at 3 weeks, P`0.001, and vs lean at 0 weeks, P`0.001. Panel B shows other carcass fat. Symbols, lines and labels as in Panel A. CL-fa/fa at 4 weeks vs S-fa/fa at 4 weeks, P`0.05 and vs fa/fa at 0 weeks, N.S. S-fa/fa at 4 weeks vs fa/fa at 0 weeks, P`0.05. CL-lean at 3 weeks vs S-lean at 3 weeks, P`0.01 and vs lean at 0 weeks P`0.05. S-lean at 3 weeks vs lean at 0 weeks, N.S. Figure 2 Food intake and resting metabolic rates. Panel A shows food intake during the treatment for saline (S) and CL (CL) treated lean and fa/fa rats. S-fa/fa ate more than S-lean (P`0.001). CL reduced food intake in fa/fa (P`0.001) but had no signi®cant effect on food intake in lean. Panel B shows resting metabolic rate measured during weeks 2±3. It is signi®cantly higher (P`0.001) in CL-treated than in S-treated rats for both genotypes. S-fa/fa metabolic rate is higher than that for S-lean (P`0.05). It is also signi®cantly higher in CL-fa/fa rats than in CLlean rats (P`0.001). Rectal temperatures of the rats were 37.7 AE 0.20 (S-lean), 37.9 AE 0.15 (CL-lean), 37.6 AE 0.16 (S-fa/fa), 37.9 AE 0.21 (CL-fa/fa). There are no signi®cant differences in rectal temperature.
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M Ghorbani and J Himms-Hagen markedly by CL-treatment ( Figure 9 ). Protein content and UCP content of BAT were 50% lower in fa/fa rats than in lean rats but were substantially increased by the CL-treatment ( Figure 9A and 9B). As in our previous study, 6 DNA content of IBAT was not altered by CL-treatment (not shown).
Both serum glucose and serum insulin concentrations were elevated in the fa/fa rats and were reduced by the CL-treatment ( Figure 10A and 10B ).
Discussion
CL-treatment induced negative energy balance in old genetically obese, fa/fa rats. This was associated with both a very marked increase in energy expenditure of 70% and suppression of the hyperphagia to a normal level. In lean rats, the treatment did not induce any change in food intake and induced a smaller increase in energy expenditure of 40%. The fa/fa rats thus differ from lean rats in that their energy balance, both energy intake and energy expenditure, is much more responsive to chronic CL 316,243-treatment. We do not know why some fa/fa rats died. The fa/fa rats were much more responsive to the treatment than were the lean rats, with suppression of their hyperphagia and a very marked increase in energy expenditure. It is possible that some died of hyperthermia whereas those which survived did not produce enough excess heat to become hyperthermic.
One plausible explanation for the difference in the food intake response between fa/fa and lean rats can Figure 3 Size and number of white adipocytes in RWAT as assessed by the osmium ®xation method. 11 Symbols, lines and labels as in Figure 1 . Panel A shows the size of white adipocytes. CL-fa/fa at 2 weeks vs S-fa/fa at 2 weeks, N.S., vs fa/fa at 0 weeks, P`0.05. CL-lean at 3 weeks vs S-lean at 3 weeks, P`0.001 and vs lean at 0 weeks, P`0.001. Panel B shows the total number of white adipocytes. There are no signi®cant differences for fa/fa rats except the total number of cells was greater (P`0.001) than in lean rats. There are no signi®cant differences for lean rats. Figure 1 . Panel A shows DNA content. DNA content is higher in fa/fa rats than in lean rats (P`0.001). CL-fa/fa at 2 weeks vs S-fa/fa at 2 weeks, P`0.05 and vs fa/fa at 0 weeks, P`0.05. CL-lean rats at 3 weeks vs S-lean rats at 3 weeks, P`0.01 and vs lean rats at 0 weeks, P`0.001. Panel B shows total protein content. CL-fa/fa at 2 weeks vs S-fa/fa at 2 weeks, P`0.001 and vs fa/fa at 0 weeks, P`0.001. CL-lean rats at 3 weeks vs S-lean rats at 3 weeks, P`0.001 and vs lean rats at 0 weeks, P`0.001.
Treatment of obese fa/fa rats with CL 316,243 M Ghorbani and J Himms-Hagen be made in terms of what is now known about leptin and leptin receptors. In the lean rats the CL-treatment would be expected to reduce leptin levels as the white adipocytes shrink, 13±16 thus promoting a compensatory increase in food intake, but at the same time to increase heat production by BAT, thus promoting a decrease in food intake. 17 The overall effect would be prevention of any compensatory increase in food intake to meet the increased expenditure, as was seen in the lean rats in this and in our previous studies. However, fa/fa rats are remarkably insensitive to stimuli that reduce leptin levels in lean animals. 13 ,18±20 In addition, the fa/fa rat is presumed to be hyperphagic at least in part because of lack of central sensitivity to its own elevated leptin levels.
19±23 Thus, because of resistance to changes in leptin levels and to central effects of leptin itself any potential effect of CLtreatment to modify feeding via changes in leptin levels would not be sensed centrally and thus would not have any in¯uence on feeding behavior. However, the effect of CL to increase heat production would still be sensed in the fa/fa rat and would result in reduced food intake. The overall effect would thus be prevention of the hyperphagia of the fa/fa rats.
The diabetic state of the fa/fa rats was improved by the CL-treatment in that both glucose and insulin levels were markedly decreased. Presumably insulinsensitivity was improved, although we did not measure this directly. It has recently been reported that CL-treatment of another type of obese rat (ZDF/Gmifa rat) markedly increased insulin action and glucose uptake into brown and white adipose tissues and skeletal muscles as well as increasing oxygen uptake by over 50%. 24 It is conceivable that uptake of glucose was primarily into brown adipocytes in all these tissues, since treatment of obese KK mice with CL induces appearance of patches of brown adipocytes in muscle as well as in WAT. 25 Although fa/fa rats have down-regulated b 3 -adrenoceptors in the BAT 26, 27 and appear to regulate these receptors differently from lean rats 27, 28 and although treatment with a b 3 -adrenoceptor agonist itself downregulates b 3 -adrenoceptors, 28 they do nonetheless exhibit a very marked response to the action of the Treatment of obese fa/fa rats with CL 316,243 M Ghorbani and J Himms-Hagen Figure 6 Immunohistochemical detection of UCP in RWAT. UCP in 10 mm sections of RWAT of lean, CL-treated (A), fa/fa, CL-treated (B), lean, saline-treated (C) and fa/fa, saline-treated (D) rats. Magni®cation 6 400. Multilocular cells in CL-treated rats contain UCP (black stain), hence are de®ned as brown adipocytes They are less apparent in the fa/fa rat (B) than in the lean rat (A) but note that the WAT of the fa/fa rat weighed more than fourteen times as much as the WAT of the lean rat (Table 1 ). The substantial increase in energy expenditure induced by the CL-treatment was associated with alterations in two distinct populations of brown adipocytes, the presumed target for this effect, in both lean and fa/fa rats. First, there was expansion of the mitochondrial compartment in brown adipocytes in BAT. In a previous study we showed that there was no change in the relative proportions of different cell types in BAT of CL-treated rats, 6 hence conclude in the present study that the 10-fold increase in UCP content occurred in brown adipocytes already present. Second, abundant multilocular brown adipocytes that expressed UCP appeared in what is usually regarded as white adipose tissue, RWAT. Their appearance was accompanied by a large increase in total protein content of the WAT, presumably due to the marked proliferation of mitochondria in these cells. The overall increase in thermogenesis induced by CL thus apparently occurred in two distinct populations of thermogenically competent brown adipocytes, those in BAT and those induced to appear in WAT by the drug treatment.
The almost 40% loss of mass of RWAT was apparently mainly due to shrinking of the white adipocytes. The number of white adipocytes, sevenfold higher in the fa/fa rats, was not altered by the drug-treatment, although we cannot exclude the possibility that a longer-term treatment might reduce this number. Comparison of the total number of cells in WAT as assessed from DNA content and the white adipocyte number as assessed by the osmium ®xation method suggests that the proportion of white adipocytes in retroperitoneal WAT is lower than generally Figure 8 Fluorescence micrograph of propidium iodide-stained RWAT. These are 10 mm sections of propidium iodide-stained sections of RWAT of CL-treated lean rats (A), CL-treated fa/fa rats (B), saline-treated lean rats (C) and saline-treated fa/fa rats (D) viewed by¯uorescence microscopy. Magni®cation 6 400. The small white spheres are nuclei. White adipocytes appear as larger black spheres. Since these are 10 mm sections and the average adipocyte diameter is 80±120 mm, relatively few of the nuclei can be present in adipocytes. The non-adipocyte nuclei are clearly seen in saline-treated rats (C and D). They become much more apparent in CL-treated rats (A and B), probably due to the shrinkage of the white adipocytes in these drug-treated animals. Indeed, they can barely be distinguished from each other in these fairly thick sections. These sections provide visible con®rmation that white adipocytes are not the predominant cell type in WAT, when considered as proportion of total cells present (see Table 1 ).
thought. The appearance of abundant stained nuclei in the 10 mm sections stained with propidium iodide strengthens this conclusion. Mature white adipocytes have an average diameter of 80±120 mm and relatively few of their nuclei could be present in a 10 mm section. A similar low value is suggested by other work. 9 However, the very marked elevation in total cell number in WAT in the obese fa/fa rats was reduced by the CL-treatment and was presumably due to loss of non-adipocyte nuclei. This reduction occurred at a time when brown adipocytes were actually appearing in the tissue and white adipocytes remaining unchanged in number. A possible explanation for the nature of the non-adipocyte cells which disappeared from WAT of the fa/fa rats is offered here. They are suggested to be vascular cells, recruited to support the increased circulation of blood in the grossly expanded mass of the WAT and lost when the mass decreases under the in¯uence of the drug. Angiogenic properties of WAT have long been recognized. 29 Indeed, the principal components of the renin-angiotensin system (RAS) are present in WAT and believed to play a role in control of the cellularity of the tissue. 30, 31 Angiotensinogen production is increased in obesity and is under nutritional regulation. 32, 33 While there is some information about the role of angiogenesis in altered blood¯ow in WAT in obesity 30 mechanisms involved in the disappearance of the expanded vasculature of WAT when its fact content has been reduced appear to have been neglected. Figure 1 . Panel A shows serum glucose concentration. CL-fa/fa at 2 weeks vs S-fa/fa at 2 weeks, P`0.001, and vs fa/fa at 0 weeks, P`0.05. CL-lean at 3 weeks vs S-lean at 3 weeks and vs lean at 0 weeks, not signi®cant. Glucose is higher in fa/fa than in lean at 0 weeks (P`0.05) and in S-fa/fa than in Slean at 2±3 weeks (P`0.001). There is no signi®cant difference between CL-fa/fa and CL-lean at 2±3 weeks. Panel B shows serum insulin concentration. CL-fa/fa at 2 weeks vs S-fa/fa at 2 weeks and vs fa/fa at 0 weeks, P`0.001. CL-lean at 3 weeks vs S-lean at 3 weeks and vs lean at 0 weeks, P`0.05. Insulin is higher in fa/fa than in lean at 0 weeks and in S-fa/fa than in S-lean at 2±3 weeks (P`0.001). There is no signi®cant difference between CL-fa/fa and CL-lean at 2±3 weeks. Figure 1 . Panel A shows UCP content. CL 2 or 3 weeks vs S at 2 or 3 weeks and vs rats at 0 weeks, P`0.001 for both genotypes. fa/fa at 0 weeks vs lean at 0 weeks, P`0.005, and at 2±3 weeks, P`0.001. Panel B shows total protein content. CL 2 or 3 weeks vs S at 2 or 3 weeks and vs rats at 0 weeks, P`0.001 for both genotypes. fa/fa at 0 weeks vs lean at 0 weeks, P`0.001, and at 2±3 weeks, P`0.001.
The origin of the multilocular, UCP-expressing cells which appeared in RWAT of CL-treated rats is unknown. Their expression of UCP de®nes them as brown adipocytes. 8 Possible explanations for their origin have been discussed elsewhere 7 and will require further study. That they appear in such abundance in the grossly enlarged WAT depots of fa/fa rats, together with the much larger increase in resting metabolic rate in the fa/fa rats than in the lean rats (or in the diet-induced obese rats studied previously) suggests that the availability of brown adipocyte precursors in the white adipose tissue depots might have been greater in these obese rats, perhaps because of the much greater number of total cells in these depots. If the cells have a vascular origin, 34 the greater vascularity of the WAT in the fa/fa rat could provide an explanation for the greater abundance of these precursor cells, which would differentiate into brown adipocytes as the vasculature was remodelled under the in¯uence of the drug. The greater availability of precursors to brown adipocytes in WAT of fa/fa rats provides a plausible explanation for the enhanced thermogenic responsiveness of obese fa/fa rats, compared with lean rats, to stimulation by b 3 -adrenoceptor agonists. It raises hope that similar abundant brown adipocyte precursors might be present in WAT depots of adult obese humans. Indeed, precursor cells isolated from adult human adipose tissues and differentiating in culture have recently been shown to express UCP when stimulated with b 3 -adrenoceptor agonists, including CL 316,243, 35 suggesting that such precursor cells might indeed be present.
